Schedule a Meeting
Get a SampleJanuary 2025
The global hyperbaric oxygen therapy market size is calculated at USD 3.98 billion in 2025 and is forecasted to reach around USD 6.71 billion by 2034, accelerating at a CAGR of 5.96% from 2025 to 2034. The North America market size surpassed USD 1.17 billion in 2024 and is expanding at a CAGR of 6.07% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global hyperbaric oxygen therapy market size accounted for USD 3.76 billion in 2024 and is predicted to increase from USD 3.98 billion in 2025 to approximately USD 6.71 billion by 2034, expanding at a CAGR of 5.96% from 2025 to 2034. The growth of the hyperbaric oxygen therapy market is driven by rising incidences of chronic wounds, increasing awareness about advanced treatments, and the expanding scope of applications of hyperbaric oxygen therapy in neurological conditions.
By integrating artificial intelligence models with health records and imaging systems, the decision-making process is greatly accelerated, leading to improved patient outcomes. While real-world data extraction and analysis was previously painstaking and time-consuming, AI can analyze the information captured in electronic health records and image repositories very quickly to create personalized treatment plans, optimizing the effectiveness of hyperbaric oxygen therapy. AI also helps with patient monitoring. With AI-driven RPM tools, continuous monitoring of patients during hyperbaric oxygen therapy is possible. This, in turn, reduces anomalies and enhances patient outcomes.
The U.S. hyperbaric oxygen therapy market size was exhibited at USD 0.94 billion in 2024 and is projected to be worth around USD 1.72 billion by 2034, growing at a CAGR of 6.22% from 2025 to 2034.
What Factors Contributed to North America’s Dominance in the Hyperbaric Oxygen Therapy Market?
North America registered dominance in the market by capturing the largest revenue share of 31% in 2024. Factors such as accredited hyperbaric centers by the Undersea & Hyperbaric Medical Society (UHMS), the presence of robust healthcare infrastructure, and the prevalence of chronic wounds and inflammation due to diabetes are major factors that contribute to regional market growth. The favorable regulatory environment and the availability of reimbursement policies for HBOT bolstered the growth of the market in the region. The region’s dominance is reinforced by the US’s longstanding commitment to the healthcare, supported by federal government insurance programs and private insurers, ensuring support for hyperbaric treatment. Clinical research and the growing awareness of hyperbaric therapy benefits for radiation injury and carbon monoxide further support regional market growth. Additionally, the presence of major market players and investments into medical technology further solidify the region’s position in the market.
European Hyperbaric Oxygen Therapy Market Trends
Europe was the second-largest market in 2024 and is expected to grow at a significant rate in the upcoming period, mainly due to its highly developed healthcare systems, robust reimbursement structures, and increasing patient demand for non-invasive treatments. The rising burden of chronic wounds, post-surgical complications, and neurological conditions is boosting the acceptance of hyperbaric oxygen therapy (HBOT). Germany is a significant player in the European hyperbaric oxygen therapy market. It has a well-developed network of accredited hyperbaric facilities, improving accessibility to HBOT and facilitating rapid integration in hospitals and clinics for the treatment of common ailments such as vascular conditions, traumatic brain injuries, or sports injuries.
Asia Pacific Hyperbaric Oxygen Therapy Market Trends
Asia Pacific is projected to grow at a CAGR of 6.5% during the forecast period. The growth of the market within Asia Pacific is driven by increasing healthcare spending, growing awareness of treatment options, and the growing middle-class population. There is rising demand for non-invasive therapies to treat chronic wounds, aid recovery from surgery, and treat complications from diabetes, supporting regional market growth. Medical tourism in countries such as India, Thailand, and Malaysia is rising, leading to increased demand for HBOT to attract international patients. Improved hospital accessibility and favorable reimbursement policies are also accelerating the adoption of HBOT.
China is a major force in the market due its large patient pool, government-driven healthcare reforms, investment in hospital infrastructure, and the integration of HBOT across hospitals for treating various conditions, including diabetic foot ulcers, neurological injuries, and wounds. Public and private hospitals are equipped with more modern hyperbaric chambers, and research institutions are investing heavily in clinical trials using HBOT for diverse indications. These factors contribute to market growth.
Hyperbaric oxygen therapy (HBOT) is a medical treatment in which a patient breathes pure oxygen in a pressurized chamber to increase oxygen delivery to tissue. This process increases the amount of oxygen delivered to the tissue and leads to increased healing in conditions such as non-healing wounds, carbon monoxide, decompression sickness, and radiation injuries. The hyperbaric oxygen therapy market is poised for consistent growth due to the increasing incidence of non-healing wounds and complications related to diabetes. With various emerging applications in the neurology field, the demand for HBOT continues to grow relative to mainstream medical practices.
The rising development of portable hyperbaric chambers and research suggesting advances in wound care further contribute to market growth. The number of clinical practices that are incorporating HBOT in their practice has increased over the years. There is continued innovation in the hyperbaric chamber, which is likely to sustain market growth in the near future.
| Report Coverage | Details |
| Market Size by 2034 | USD 6.71 Billion |
| Market Size in 2025 | USD 3.98 Billion |
| Market Size in 2024 | USD 3.76 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 5.96% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Type, Application, End-User and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Increasing Prevalence of Diabetes and Technological Advancements
The increasing prevalence of diabetes across the world is a significant factor driving the growth of the hyperbaric oxygen therapy market. According to the World Health Organization (WHO), in 2021, there were about 537 million adults aged between 20-79 years living with diabetes and it is expected to rise to 643 million by 2030 and 783 million by 2045. The increasing prevalence of diabetes leads to an increase in the number of cases of diabetic foot ulcers and chronic wounds, significantly creating the need for HBOT. HBOT works by driving oxygen into hypoxic tissue, which promotes angiogenesis, helps resolve the sclerosis of the wound, and reduces the incidence of amputation. In addition to the increasing use of HBOT to treat diabetes-related complications, there is continuous innovation in hyperbaric oxygen therapy. Advancements in hyperbaric chambers, including portable and user-friendly chambers, are improving the efficiency and safety of HBOT to be utilized in hospital settings and ambulatory care centers.
(Source: https://www.emro.who.int)
High Costs and Safety Concerns
Despite its therapeutic advantages, hyperbaric oxygen therapy (HBOT) is not widely adopted because of significant barriers. The high costs associated with HBOT and limited reimbursement policies limit accessibility to some patients, especially those in low-income groups. Safety issues also have been highlighted by the sudden hyperbaric chamber explosion in Michigan in January 2025, which led to the death of a five-year-old boy. In addition, there are concerns about the adequacy of safety measures and regulatory procedures in HBOT facilities.
(Source: https://www.holmesmurphy.com)
Furthermore, side effects associated with HBOT, including seizures, toxicity, and injuries to the middle ear, create the need for extensive screening and safety precautions for patients. These include safety protocols and the need for qualified personnel. Together, these issues evoke hesitation from both patients and practitioners, resulting in significant barriers to broader market expansion.
Integration of HBOT into Wellness and Home-Based Care
The hyperbaric oxygen therapy market is experiencing a revolutionization through the market's entry into luxury wellness and home care models. There is a marked increase in the number of HBOT chambers being installed in luxury real estate, particularly in cities like London, Los Angeles, and Dubai, where "longevity rooms" are becoming the new status symbol. The longevity rooms include bio-optimization tools like HBOT units with other amenities desired for enhancing cognitive performance, anti-aging, and physical recovery. At the same time, social wellness clubs like Remedy Place in New York are offering HBOT as part of a collective health experience.
Technological advancement has now made it possible for patients to receive HBOT under the supervision of healthcare personnel through telemedicine platforms. This enables patients to recover from a wound or injury at the convenience of their homes. This decentralization of therapy delivery supports the broader trends in telehealth and is likely to increase market reach, especially as more wellness practices become paramount to individualized healthcare.
Why did the Monoplace Chambers Segment Dominate the Market in 2024?
The monoplace chambers segment dominated the hyperbaric oxygen therapy market with the largest revenue share in 2024. This is mainly due to their affordability, simplicity, and ability to fit well within multiple healthcare environments, such as hospitals and ambulatory surgical centers. Monoplace chambers allow for single use and mitigate cross-contamination risks, simplifying infection control for clinical settings. They are suitable for smaller-level facilities, so outpatient centers and private clinics can use monoplace chambers. The ease of installation and cost-effectiveness of these chambers are crucial factors supporting segmental growth.
The multiplace chambers segment is expected to grow at a significant CAGR during the forecast period. The adoption of multiplace chambers is rising rapidly due to their ability to treat up to 14 patients in one cycle. These chambers are valuable in general emergency care and for large hospitals, particularly for mass injuries or decompression sickness affecting groups like military personnel or divers. The use of multiplace chambers is also increasing as knowledge of hyperbaric medicine rises and trauma center regulations incorporate the representation of hyperbaric medicine. Furthermore, multiplace chambers offer specific advantages in hospital settings, enabling treatment for patients requiring mechanical ventilation or intensive monitoring.
Which Application Segment Dominated the Hyperbaric Oxygen Therapy Market in 2024?
The wound healing segment dominated the market with the largest revenue share in 2024. This is mainly due to the efficacy of HBOT in promoting tissue repair and reducing the risk of infection. It can be very effective for chronic, non-healing wounds, such as diabetic foot ulcers, pressure ulcers, and injuries from radiation therapy. The worldwide increase in the incidence of diabetes and peripheral vascular disease has led to more clinical adoption of hyperbaric oxygen therapy in wound care centers and hospitals. As evidence supporting its efficacy accumulates, this treatment is becoming a core therapy in advanced wound care.
The decompression sickness segment is expected to expand at the fastest CAGR over the projected period, driven by the increasing number of recreational scuba divers and professional diving operations. As more people take part in underwater-related activities, the need for emergency decompression treatment increases. In addition, segment growth can be attributed to the increasing awareness of health issues associated with diving and the establishment of hyperbaric facilities in remote areas and close to water. Military and commercial diving units continue to buy hyperbaric chambers, contributing to segmental growth.
How Does the Hospitals Segment Dominate the Market in 2024?
The hospitals segment dominated the hyperbaric oxygen therapy market in 2024 since they have advanced infrastructure and can offer robust medical services under a single roof. Hospitals also typically have skilled staff and monitoring equipment, which are necessary when using hyperbaric chambers skillfully and safely, particularly in complicated cases such as carbon monoxide poisoning, secondary infections, and chronic wounds. The rise of hyperbaric units being included in multidisciplinary hospital services enhances wider accessibility to HBOT, especially in urban healthcare systems. Hospitals also have established reimbursement systems for hyperbaric oxygen therapy, contributing to the growth of the segment.
The home care segment is expected to expand at a rapid pace during the projection period as patients are increasingly preferring home treatments, especially elderly and chronically ill patients. The development of portable hyperbaric chambers and RPM have enabled patients to receive therapy in the convenience of their homes under medical supervision. Home healthcare providers are also expanding their service offerings to include this advanced therapy.
(Source: https://www.expresshealthcare.in)
By Type
By Application
By End-User
By Region
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
January 2025
May 2025
November 2024
October 2024